Skip to main navigation Skip to search Skip to main content

Ribavirin rather than PEG-interferon pharmacodynamics predict nonresponse to antiviral therapy in naive chronic hepatitis C patients

  • L.G. van Vlerken
  • , E.J. Huisman
  • , H. van Soest
  • , G.J. Boland
  • , J.P. Drenth
  • , P.D. Siersema
  • , D.M. Burger
  • , K.J. van Erpecum

Research output: Contribution to journalArticleAcademicpeer-review

Cite this